Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Recurrence 2Prostatic Neoplasms 1Myofibroma 1Multiple Myeloma 1Lymphoma, Follicular 1Leukemia, Myeloid, Acute 1Leiomyoma 1Insulin Resistance 1Endometriosis 1Dementia 1Cognitive Dysfunction 1Alzheimer Disease 1

Interventions

Tablets 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Myofibroma × Tablets × Clear all
NCT03156127 2017-08-10

A Study to Compare the Pharmacokinetics and Safety/Tolerability of BR-UPS (Ulipristal Acetate) 5 mg Tablet With Inisia (Ulipristal Acetate) 5 mg Tablet

Boryung Pharmaceutical Co., Ltd

Phase 1 Withdrawn

Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡